MBNL splicing activity depends on RNA binding site structural context
Taylor K, Sznajder LJ, Cywoniuk P, Thomas JD, Swanson MS, Sobczak K. Nucleic Acids Res. 2018 Jun 28. PubMed
SRB-2: a promiscuous rainbow aptamer for live-cell RNA imaging
Sunbul M, Jäschke A. Nucleic Acids Res. 2018 Jun 21. PubMed
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Springer AD, Dowdy SF. Nucleic Acid Ther. 2018 Jun;28(3):109-118. PubMed
Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
Kulkarni JA, Cullis PR, van der Meel R. Nucleic Acid Ther. 2018 Jun;28(3):146-157. PubMed
Current Status of Messenger RNA Delivery Systems
Stanton MG. Nucleic Acid Ther. 2018 Jun;28(3):158-165. PubMed
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
Juliano RL. Nucleic Acid Ther. 2018 Jun;28(3):166-177. PubMed
Aptamer-Mediated Delivery and Cell-Targeting Aptamers: Room for Improvement
Yan AC, Levy M. Nucleic Acid Ther. 2018 Jun;28(3):194-199. PubMed
Circular RNAs in Cancer – Lessons Learned From microRNAs
Dragomir M, Calin GA. Front Oncol. 2018 May 28;8:179. PubMed
Identifying and avoiding off-target effects of RNase H-dependent antisense oligonucleotides in mice
Hagedorn PH, Pontoppidan M, Bisgaard TS, Berrera M, Dieckmann A, Ebeling M, Møller MR, Hudlebusch H, Jensen ML, Hansen HF, Koch T, Lindow M. Nucleic Acids Res. 2018 May 22. PubMed
Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr-/- mice
Rajamoorthi A, Lee RG, Baldán Á. Atherosclerosis. 2018 May 24;275:43-49. PubMed
